Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Daniel, Peter Prof. Dr. (1) Jarosch, Ernst Dr. (5) Kammertöns, Thomas Dr. (5) Kettenmann, Helmut Prof. Dr. (31) Kopp, Joachim Dr. (1) Krabbe, Grietje Dr. (1) Ku, Min-Chi Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (1) Maglione, Marta (1) Nolte, Christiane Dr. (6) Pezzutto, Antonio Prof. Dr. (2) Quensel, Christina Dr. (1) Selbach, Matthias Prof. Dr. (1) Semtner, Marcus Dr. (1) Siffrin, Volker (1) Sommer, Thomas Prof. Dr. (11) Willimsky, Gerald Dr. (1) Wolf, Susanne Dr. (5) (-) Blankenstein, Thomas Prof. Dr. (16) (-) Nguyen, Tam Hoai Dr. (1) (-) Uckert, Wolfgang Prof. Dr. (5) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (7) 2003 (9) (-) 2004 (9) 2005 (11) 2006 (1) 2007 (6) 2008 (6) 2009 (2) 2010 (7) (-) 2011 (6) 2012 (6) 2013 (11) (-) 2014 (3) 2015 (3) 2016 (6) 2017 (7) 2018 (7) 2019 (6) 2021 (4) 2022 (6) 2023 (4) 2024 (2) (-) Cellular Neurosciences (1) Epigenetic Regulation and Chromatin Architecture (9) From Cell States to Function (1) (-) Intracellular Proteolysis (1) Molecular Cardiovascular Research (1) (-) Molecular Immunology and Gene Therapy (16) Pancreatic Organoid Research and Disease Modeling (1) Proteome Dynamics (1) RNA Biology and Posttranscriptional Regulation (1) Systems Biology of Gene Regulatory Elements (3) Translational Oncology of Solid Tumors (1) 18 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Nguyen, Tam Hoai Dr.Uckert, Wolfgang Prof. Dr.Cellular NeurosciencesIntracellular ProteolysisMolecular Immunology and Gene Therapy200420112014 Sort: Result score Newest to oldest Oldest to newest January 01, 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein January 01, 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto August 01, 2004 / Immunity CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions L. Ohl M. Mohaupt N. Czeloth G. Hintzen Z. Kiafard J. Zwirner T. Blankenstein G. Henning R. Foerster July 01, 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein January 15, 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens April 01, 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto January 01, 2004 / Nat Immunol A cancer immunosurveillance controversy Z.H. Qin T. Blankenstein January 01, 2004 / Int J Cancer CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells J.A. Lindencrona S. Preiss T. Kammertoens T. Schueler M. Piechocki W.Z. Wei B. Seliger T. Blankenstein R. Kiessling January 01, 2004 / J Immunol Long-term suppression of tumor growth by TNF requires a Stat1- and IFN regulatory factor 1-dependent IFN-γ pathway but not IL-12 or IL-18 T.H. Wu C.N. Pabin Z.H. Qin T. Blankenstein M. Philip J. Dignam K. Schreiber H. Schreiber January 23, 2004 The role of inflammation for tumour growth and tumour suppression T. Blankenstein Pagination Current page 1 Page 2 Next page Next › Last page Last »
January 01, 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein
January 01, 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto
August 01, 2004 / Immunity CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions L. Ohl M. Mohaupt N. Czeloth G. Hintzen Z. Kiafard J. Zwirner T. Blankenstein G. Henning R. Foerster
July 01, 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein
January 15, 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
April 01, 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
January 01, 2004 / Int J Cancer CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells J.A. Lindencrona S. Preiss T. Kammertoens T. Schueler M. Piechocki W.Z. Wei B. Seliger T. Blankenstein R. Kiessling
January 01, 2004 / J Immunol Long-term suppression of tumor growth by TNF requires a Stat1- and IFN regulatory factor 1-dependent IFN-γ pathway but not IL-12 or IL-18 T.H. Wu C.N. Pabin Z.H. Qin T. Blankenstein M. Philip J. Dignam K. Schreiber H. Schreiber